Login

Christoph Vilanek, CEO of Freenet AG, speaking at the 10th International Brand Colloquium in 2013. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Brendan Caldwell Answers Key Investing Questions for Canadians"
00:10:00
A preview of the Rule Symposium featuring Rudi Fronk, CEO of Seabridge Gold, providing valuable insights into the gold market and investment opportunities| Rudi Fronk, CEO of Seabridge Gold
00:10:00
U.S. Leadership in Emerging Technologies: Insights from Lux Capital's Josh Wolff | Josh Wolfe, Co-Founder, Lux Capital .
00:00:00
Corline Biomedical at Pareto Securities' Health Care Conference - Henrik Nittmar , CEO, Corline Biomedical
00:00:00
Predictive modeling driven behavioral healthcare services to health plans - Terren Peizer, Chairman & CEO of Catasys, Inc.
00:10:00
Development of a new generation of immune response modifier|Simon Wilkinson,CEO,Innate Immunotherapeutics Ltd
00:10:00
Lloyds' Strategic Focus on UK Prosperity and Digital Investment | Antonio Horta-Osorio, CEO, Lloyds Banking Group.
00:10:00
Sabina Gold: Advancing High-Grade Gold Development in Northern Canada
00:10:00
Investing in dreams at the earliest stage|Adina Davis,Principal,BoxGroup
00:10:00
Early-stage fund that wants to be with its founders throughout their journey|Yves Sisteron,Managing Partner,Upfront Ventures
00:10:00
The Phoenix Gold Project: Achieving Commercial Production
00:10:00
Navigating Private Capital Markets: Insights from Jean Phillippe Keravec at IPEM 2020

© 2026 Nehu